GSK on Tuesday said Japan’s Ministry of Health, Labour and Welfare approved Exdensur, also known as depemokimab, for patients ...

Some "Today" show viewers may have noticed Savannah Guthrie is missing, but the popular host's absence is only temporary.

GSK (NYSE:GSK) notched a solid regulatory win in Japan, with health authorities approving Exdensur for patients with severe ...

Savannah Guthrie, the beloved co-anchor of NBC's Today, has recently shared an uplifting health update following her vocal surgery. This article delves into her journey, the significance of vocal ...

Savannah Guthrie's vocal cord surgery resulted in her taking a few weeks off from 'Today' to rest, and she gave fans a health ...

GSK said Japan's Ministry of Health had approved its bronchial asthma treatment Exdensur after trial results showed ...

Symptoms often include facial pressure, congestion and fatigue — It affects about 37 million Americans each year — Infections ...

While her return to her TODAY family hasn't been announced yet, Guthrie did share an update on her condition in a January 5 ...

(Alliance News) - GSK PLC on Tuesday said depemokimab, sold under the brand name Exdensur, has been approved by Japan's Ministry of Health, Labour and Welfare for severe asthma and chronic ...

Bambusa Therapeutics, Inc., a clinical-stage biotechnology company pioneering next-generation bispecific antibodies ...

Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on ...

WHEN James Rogers first spotted blood in his poo his doctors insisted it wouldn’t be cancer. They even ran blood tests on the ...